MDxHealth is trading at $0.16, down 8.94%, with no specific October 30 company announcement or report found to explain the decline.
- The latest company news announced a November 12 results date.
- The earlier Q3 revenue shortfall and suspension of full-year guidance remain background concerns, but predate this move. Healthcare stocks were higher, so the sector trend does not explain the decline.
- No verified intraday volume data was found.